We recognize that the association of the upregulation of CB1 and CB2 to that of cytokines in MS does not imply causation, in particular as concentration of cytokines likely to be found in body fluids in MS was less potent than the doses used in vitro on control cells in the first part of the study. The gene discussed is CNR1; the disease is myeloid sarcoma.